Akanda corp. entered into non-binding letter of intent for sale of rpk

London, united kingdom--(newsfile corp. - february 1, 2024) - akanda corp. (nasdaq: akan) ("akanda" or the "company"), an international medical cannabis company, today announces it has entered into an amended non-binding letter of intent ("loi")with somai pharmaceuticals ltd. for the sale of rpk, its portuguese subsidiary.
AKAN Ratings Summary
AKAN Quant Ranking